Risk Assessment of Long-Haul Truck Drivers

International studies have repeatedly documented a substantial prevalence of sexual risk behaviors and high rates of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI) ranging from 5%-56% amongst long-distance truck drivers ("truckers") living in diverse international settings including India, Bangladesh, South Africa, China, Laos and Thailand. The prevalence of sexual risk factors and STI/HIV in US drivers is unknown. This proposal will provide both qualitative and quantitative data on HIV risk behaviors by interviewing and testing truckers working for established long-distance trucking firms, the sector which accounts for most of the jobs in the trucking and warehousing industry in the United States. The data obtained from this study will be used to inform the development of an HIV prevention intervention for long-haul truck drivers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gonorrhea Acquired Immunodeficiency Syndrome Bacterial Infections Bacterial Infections and Mycoses Blood-Borne Infections Body Weight Cardiovascular Diseases Chlamydia Infections Chlamydiaceae Infections Communicable Diseases DNA Virus Infections Diabetes Mellitus Digestive System Diseases Dyslipidemias Endocrine System Diseases Flaviviridae Infections Genital Diseases Glucose Metabolism Disorders Gram-Negative Bacterial Infections HIV Infections Hepadnaviridae Infections Hepatitis Hepatitis B Hepatitis C Hepatitis, Viral, Human Hyperlipidemia Hyperlipidemias Hypertension Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Lipid Metabolism Disorders Liver Diseases Metabolic Diseases Neisseriaceae Infections Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Bacterial Sexually Transmitted Diseases, Viral Signs and Symptoms Slow Virus Diseases Urogenital Diseases Vascular Diseases Virus Diseases

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

About this study

The study proposed in this R34 application will address the following specific aims:

Specific Aim 1. To perform focus groups and in-depth interviews with long-haul truck drivers to guide development of both a behavioral risk assessment instrument and an acceptable HIV/STI screening protocol for long-haul truckers.

Specific Aim 2. To perform in-depth interviews with trucking industry executives to determine barriers to routine HIV/STI assessment and screening of their employees.

Specific Aim 3. To perform a pilot phase with a subsample of long-haul truck drivers characterized by the following steps: TTM-based "cognitive interviews" (N=5); pilot testing of the survey and biomedical screening protocol (N=15); and a follow-up focus group (N=8)

Specific Aim 4. To assess a sample of (N=300) truck drivers for general health and sexual risk behaviors using the adapted theory-based survey and to determine the prevalence of hepatitis B, hepatitis C, hypertension, hyperlipidemia, diabetes and obesity, HIV, N. gonorrhoeae, and C. trachomatis

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Long-haul truck driver as defined as a driver, part-time or full-time, who drives a truck across state lines (interstate)
English speaking
Age 21 or greater
Willing to participate
Able to provide written informed consent

Exclusion criteria

Does not fit definition of truck driver in inclusion criteria #1
Unwilling to participate
Unwilling or unable to provide informed consent
Unable to understand or speak English
Age < 21 years

Treatment and study plan

Primary outcomes

The prevalence of hepatitis B, hepatitis C, hypertension, hyperlipidemia, diabetes and obesity, HIV, N. gonorrhoeae, and C. trachomatis

Time frame: Cross-sectional

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Collaborators

National Institute of Mental Health (NIMH)
University of Alabama at Birmingham

Registry information

Important dates

Study start: 2005
Primary completion: 2010
Study completion: 2010
First posted: Sep 28, 2006
Registry last updated: Nov 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed